RA CAPITAL MANAGEMENT, L.P. Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$7.2T
Holdings
95
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (95 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 7,387,900 | $1.2T | 16.32% | |
| 2 | NVV1NOVAVAX INC | 2,097,794 | $434.9B | 6.03% | |
| 3 | CLYMELIEM THERAPEUTICS INC | 13,150,849 | $236.5B | 3.28% | |
| 4 | IVVDADAGIO THERAPEUTICS INC | 5,340,130 | $225.6B | 3.13% | |
| 5 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $209.0B | 2.90% | |
| 6 | CTKBCYTEK BIOSCIENCES INC | 9,607,028 | $205.7B | 2.85% | |
| 7 | AVIRATEA PHARMACEUTICALS INC | 5,427,655 | $190.3B | 2.64% | |
| 8 | JANXJANUX THERAPEUTICS INC | 8,670,644 | $187.5B | 2.60% | |
| 9 | VORVOR BIOPHARMA INC | 11,120,973 | $174.4B | 2.42% | |
| 10 | AVTEAEROVATE THERAPEUTICS INC | 8,263,982 | $173.4B | 2.40% | |
| 11 | —ICOSAVAX INC | 5,779,347 | $171.0B | 2.37% | |
| 12 | —DICE THERAPEUTICS INC | 5,208,911 | $170.6B | 2.36% | |
| 13 | CNTBCONNECT BIOPHARMA HLDGS LTD | 6,991,003 | $169.4B | 2.35% | |
| 14 | NKTXNKARTA INC | 5,605,129 | $155.9B | 2.16% | |
| 15 | ABOSACUMEN PHARMACEUTICALS INC | 9,770,773 | $145.2B | 2.01% | |
| 16 | TGTXTG THERAPEUTICS INC | 4,098,332 | $136.4B | 1.89% | |
| 17 | TVTXTRAVERE THERAPEUTICS INC | 5,614,428 | $136.2B | 1.89% | |
| 18 | TYRATYRA BIOSCIENCES INC | 7,236,454 | $127.3B | 1.76% | |
| 19 | MGNXMACROGENICS INC | 5,943,594 | $124.5B | 1.72% | |
| 20 | 5E7ITEOS THERAPEUTICS INC | 4,417,259 | $119.3B | 1.65% | |
| 21 | DAWNDAY ONE BIOPHARMACEUTICALS I | 4,965,588 | $117.8B | 1.63% | |
| 22 | IMGNEURIMMUNOGEN INC | 18,417,458 | $104.4B | 1.45% | |
| 23 | PHATPHATHOM PHARMACEUTICALS INC | 3,115,008 | $100.0B | 1.39% | |
| 24 | PCVXVAXCYTE INC | 3,896,865 | $98.9B | 1.37% | |
| 25 | ETNBGBP89BIO INC | 4,965,769 | $97.3B | 1.35% | |
| 26 | TILINSTIL BIO INC | 4,870,793 | $87.1B | 1.21% | |
| 27 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,600,000 | $86.4B | 1.20% | |
| 28 | —KINNATE BIOPHARMA INC | 3,593,052 | $82.7B | 1.15% | |
| 29 | HOWLWEREWOLF THERAPEUTICS INC | 4,291,881 | $73.6B | 1.02% | |
| 30 | TNYATENAYA THERAPEUTICS INC | 3,551,508 | $73.3B | 1.02% | |
| 31 | —POINT BIOPHARMA GLOBAL | 8,856,018 | $68.1B | 0.94% | |
| 32 | GHRSGH RESEARCH PLC | 3,013,957 | $66.5B | 0.92% | |
| 33 | RYTMRHYTHM PHARMACEUTICALS INC | 4,871,067 | $63.6B | 0.88% | |
| 34 | RCKTROCKET PHARMACEUTICALS INC COM | 2,107,149 | $63.0B | 0.87% | |
| 35 | CCCCC4 THERAPEUTICS INC | 1,377,569 | $61.5B | 0.85% | |
| 36 | CNTACENTESSA PHARMACEUTICALS PLC | 3,577,094 | $59.7B | 0.83% | |
| 37 | OLMAOLEMA PHARMACEUTICALS INC | 2,150,404 | $59.3B | 0.82% | |
| 38 | CYTCYTEIR THERAPEUTICS INC | 3,350,506 | $58.8B | 0.81% | |
| 39 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $51.0B | 0.71% | |
| 40 | —ZOGENIX INC | 3,333,700 | $50.6B | 0.70% | |
| 41 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $45.6B | 0.63% | |
| 42 | GRPHGRAPHITE BIO INC | 2,698,369 | $44.2B | 0.61% | |
| 43 | EWTXEDGEWISE THERAPEUTICS INC | 2,613,623 | $43.4B | 0.60% | |
| 44 | VERVVERVE THERAPEUTICS INC | 880,284 | $41.4B | 0.57% | |
| 45 | GONGERON CORP | 30,126,299 | $41.3B | 0.57% | |
| 46 | 698ACHILLES THERAPEUTICS PLC | 5,014,687 | $39.1B | 0.54% | |
| 47 | RXSTRXSIGHT INC | 3,052,796 | $38.7B | 0.54% | |
| 48 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $38.1B | 0.53% | |
| 49 | KALVKALVISTA PHARMACEUTICALS INC | 1,930,322 | $33.7B | 0.47% | |
| 50 | DSGNDESIGN THERAPEUTICS INC | 2,186,636 | $32.1B | 0.45% | |
| 51 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 2,378,325 | $30.1B | 0.42% | |
| 52 | SLDBSOLID BIOSCIENCES INC | 12,367,873 | $29.6B | 0.41% | |
| 53 | TNGXTANGO THERAPEUTICS INC | 2,250,000 | $29.1B | 0.40% | |
| 54 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $28.5B | 0.39% | |
| 55 | VRNAVERONA PHARMA PLC | 5,100,000 | $27.9B | 0.39% | |
| 56 | —SATSUMA PHARMACEUTICALS INC | 5,914,252 | $27.6B | 0.38% | |
| 57 | —AKOUOS INC | 2,281,249 | $26.5B | 0.37% | |
| 58 | ORTXUSDORCHARD THERAPEUTICS PLC | 11,028,722 | $25.4B | 0.35% | |
| 59 | EYPTEYEPOINT PHARMACEUTICALS INC | 2,210,506 | $23.0B | 0.32% | |
| 60 | IPSCCENTURY THERAPEUTICS INC | 914,094 | $23.0B | 0.32% | |
| 61 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $21.9B | 0.30% | |
| 62 | —SYNLOGIC INC | 6,666,666 | $20.3B | 0.28% | |
| 63 | SCPHSCPHARMACEUTICALS INC | 2,731,170 | $18.2B | 0.25% | |
| 64 | CTMXCYTOMX THERAPEUTICS INC | 3,500,000 | $17.8B | 0.25% | |
| 65 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $17.5B | 0.24% | |
| 66 | SPRYSILVERBACK THERAPEUTICS INC | 1,742,186 | $17.4B | 0.24% | |
| 67 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,436,430 | $15.0B | 0.21% | |
| 68 | —DA32 LIFE SCNCE | 1,500,000 | $14.7B | 0.20% | |
| 69 | MISTMILESTONE PHARMACEUTICALS INC | 2,246,503 | $12.8B | 0.18% | |
| 70 | —BCLS ACQUISITION CORP | 1,250,000 | $12.4B | 0.17% | |
| 71 | CATBUSDASTRIA THERAPEUTICS INC | 1,262,193 | $11.2B | 0.15% | |
| 72 | ENTXWENTERA BIO LTD | 2,353,000 | $11.1B | 0.15% | |
| 73 | TCRXTSCAN THERAPEUTICS INC | 1,255,317 | $10.5B | 0.15% | |
| 74 | RNAAVIDITY BIOSCIENCES INC | 423,616 | $10.4B | 0.14% | |
| 75 | WHWKAADI BIOSCIENCES INC | 347,668 | $10.2B | 0.14% | |
| 76 | —FS DEVELOPMENT CORP II | 1,000,000 | $9.9B | 0.14% | |
| 77 | CNCEEURCONCERT PHARMACEUTICALS INC | 3,033,603 | $9.9B | 0.14% | |
| 78 | —ARYA SCIENCES ACQUISITN CORP | 1,000,000 | $9.9B | 0.14% | |
| 79 | —FRAZIER LIFESCIENCES ACQUISITION CO | 1,000,000 | $9.8B | 0.14% | |
| 80 | —IKENA ONCOLOGY INC | 750,000 | $9.5B | 0.13% | |
| 81 | —PHASEBIO PHARMACEUTICALS INC | 2,850,000 | $8.9B | 0.12% | |
| 82 | HLTHQCUE HEALTH INC | 750,000 | $8.9B | 0.12% | |
| 83 | COGTCOGENT BIOSCIENCES INC | 1,025,641 | $8.6B | 0.12% | |
| 84 | CGEMCULLINAN ONCOLOGY INC | 350,000 | $7.9B | 0.11% | |
| 85 | OCULOCULAR THERAPEUTIX INC | 750,000 | $7.5B | 0.10% | |
| 86 | —5 01 ACQUISITION CORP | 750,000 | $7.4B | 0.10% | |
| 87 | MLTXHELIX ACQUISITION CORP | 700,000 | $7.0B | 0.10% | |
| 88 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $6.2B | 0.09% | |
| 89 | BMEABIOMEA FUSION INC | 500,000 | $6.0B | 0.08% | |
| 90 | CVRXCVRX INC | 275,000 | $4.5B | 0.06% | |
| 91 | —SYROS PHARMACEUTICALS INC | 900,000 | $4.0B | 0.06% | |
| 92 | CCXIEURCHEMOCENTRYX INC | 218,532 | $3.7B | 0.05% | |
| 93 | OTICEUROTONOMY INC | 1,631,635 | $3.1B | 0.04% | |
| 94 | OKURRENEO PHARMACEUTICALS INC | 62,217 | $464.0M | 0.01% | |
| 95 | VRDNVIRIDIAN THERAPEUTICS INC | 1,034 | $17.0M | 0.00% |